Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity. - Joe CCD; Chatterjee S; Lovrecz G; Adams TE; Thaysen-Andersen M; Walsh R; Locarnini SA; Smooker P; Netter HJ (Vaccine, 2020)